信息详情

NHS National Framework for Transition products commencing 1 October 2024

2024-06-26

中文

英语 (English)

所属地区: --

所属机构: --

抱歉,该信息暂无中文翻译信息,为您显示项目原文信息。

Published date: 26 June 2024

Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.

Watch this notice Print this notice
Closing: 29 July 2024, 1pm

Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Location of contract

    WA7 2ES

    Value of contract

    £49,320,000

    Procurement reference

    CF-2433800D0O000000rwimUAA

    Published date

    26 June 2024

    Closing date

    29 July 2024

    Closing time

    1pm

    Contract start date

    1 October 2024

    Contract end date

    31 May 2026

    Contract type

    Supply contract

    Procedure type

    Open procedure (above threshold)

    What is an open procedure (above threshold)?

    Any interested supplier may submit a tender in response to an opportunity notice.

    This procedure can be used for procurements above the relevant contract value threshold.

    Contract is suitable for SMEs?

    Yes

    Contract is suitable for VCSEs?

    No


    Description

    Project title: NHS National Framework for Transition products commencing 1 October 2024
    Offer reference number: CM/TNS/24/5712
    Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
    Potential periods of call-offs under the framework agreement:

    CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
    Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months)
    Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months)
    Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

    CM/TNS/24/5712/02 - Imatinib
    Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

    Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England


    More information

    Attachments

  • Document No. 05 - Selectt offer schedule instructions CM-TNS-24-5712.docx
  • Document No. 05 - Selectt offer schedule instructions CM-TNS-24-5712
  • Document No. 07a - Quality control technical sheet CM-TNS-24-5712.doc
  • Document No. 07a - Quality control technical sheet CM-TNS-24-5712
  • Document No. 05b(ii) - Tender Product Listing and Usage - CM_TNS_24_5712_02.xlsx
  • Document No. 05b(ii) - Tender Product Listing and Usage - CM_TNS_24_5712_02
  • Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6.1 CM-TNS-24-5712.docx
  • Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6.1 CM-TNS-24-5712
  • Document No. 04a - Quality Assurance Process CM-TNS-24-5712.doc
  • Document No. 04a - Quality Assurance Process CM-TNS-24-5712
  • Document No. 06 - Form of offer CM-TNS-24-5712.doc
  • Document No. 06 - Form of offer CM-TNS-24-5712
  • Document No. 02 - Terms of offer CM-TNS-24-5712.doc
  • Document No. 02 - Terms of offer CM-TNS-24-5712
  • Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5712.docx
  • Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5712
  • Document No. 09 - Participating Authorities - CM_TNS_24_5712.xls
  • Document No. 09 - Participating Authorities - CM_TNS_24_5712
  • Document No. 05b(i) - Tender Product Listing and Usage - CM_TNS_24_5712_01.xlsx
  • Document No. 05b(i) - Tender Product Listing and Usage - CM_TNS_24_5712_01
  • Document No. 08 - Confidential information schedule CM-TNS-05-2024.xls
  • Document No. 08 - Confidential information schedule CM-TNS-05-2024
  • Document No. 05a(ii) - Selectt Offer file - CM_TNS_24_5712_02.xml
  • Document No. 05a(ii) - Selectt Offer file - CM_TNS_24_5712_02
  • Document No. 05a(i) - Selectt Offer file - CM_TNS_24_5712_01.xml
  • Document No. 05a(i) - Selectt Offer file - CM_TNS_24_5712_01
  • Document No. 01 - Invitation to offer covering letter CM-TNS-24-5712.docx
  • Document No. 01 - Invitation to offer covering letter CM-TNS-24-5712
  • Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM-TNS-24-5712.docx
  • Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM-TNS-24-5712
  • Additional text

    To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

    Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

    Phone: 0800 9956035

    E-mail: support-health@atamis.co.uk


    How to apply

    Follow the instructions given in the description or the more information section.


    About the buyer

    Contact name

    Katie Noonan

    Address

    2nd Floor Rutland House
    Runcorn
    WA7 2ES
    GB

    Email

    katie.noonan@nhs.net


    Share this notice

    Is there anything wrong with this page?

    温馨提示:

    本网站为您提供准确和及时的招投标信息,但招投标信息存在着变更的可能,请您务必在交易前向招标代理机构或招标人咨询投标详细要求,有关招标的具体要求及情况以招标代理机构或招标人的解释为准。
           如果您对这篇招标信息有任何补充或修改建议,请告知我们。

    猜你喜欢

    首页 > 英国 > NHS National Framework for Transition products commencing 1 October 2024